warnings
WARNINGS Stop use and ask a physician if symptoms persist for more than 3 days or worsen.
RUTA GRAVEOLENS 200ck
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- RUTA GRAVEOLENS 200ck
- Generic name
- RUTA GRAVEOLENS
- Manufacturer
- SEVENE USA
- Product type
- HUMAN OTC DRUG
- SPL set ID
- cf898a11-a78e-342d-e053-2995a90a5b05
- SPL ID
- 2dcc6b2e-b3d5-e17b-e063-6294a90a2fd2
- Version
- 4
- Effective date
- 2025-02-10
- Source export date
- 2026-10-27
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
- Import run
- 20261027T193451Z
- Imported at
- 2026-10-27 20:22:45
| Harmonized routes |
|---|
| SUBLINGUAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | RUTA GRAVEOLENS 200ck | openfda.brand_name | |
| generic name | RUTA GRAVEOLENS | openfda.generic_name | |
| manufacturer name | SEVENE USA | openfda.manufacturer_name | |
| ndc | package | 76472-3032-1 | openfda.package_ndc |
| ndc | product | 76472-3032 | openfda.product_ndc |
| ndc11 | package | 76472303201 | derived:openfda.package_ndc |
| spl id | 2dcc6b2e-b3d5-e17b-e063-6294a90a2fd2 | id | |
| spl set id | cf898a11-a78e-342d-e053-2995a90a5b05 | set_id | |
| unii | N94C2U587S | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.